Published in J Thromb Haemost on December 23, 2005
Structural insights into the interactions between platelet receptors and fibrillar collagen. J Biol Chem (2009) 1.14
Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood. J Biol Chem (2012) 0.92
Structural basis for collagen recognition by the immune receptor OSCAR. Blood (2015) 0.83
Discovery of novel GPVI receptor antagonists by structure-based repurposing. PLoS One (2014) 0.79
Computer prediction of paratope on antithrombotic antibody 10B12 and epitope on platelet glycoprotein VI via molecular dynamics simulation. Biomed Eng Online (2016) 0.75
Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta (1986) 13.69
A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res (1982) 7.12
Structural basis of collagen recognition by integrin alpha2beta1. Cell (2000) 4.84
The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem (2000) 2.56
Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol (1990) 2.00
Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem (1996) 1.74
The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood (1998) 1.66
Primary and secondary agonists can use P2X(1) receptors as a major pathway to increase intracellular Ca(2+) in the human platelet. J Thromb Haemost (2007) 1.65
Nomenclature of human platelet antigens. Vox Sang (2003) 1.62
Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J (1999) 1.51
Identification in collagen type I of an integrin alpha2 beta1-binding site containing an essential GER sequence. J Biol Chem (1998) 1.51
Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc Res (1999) 1.50
Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia. Br J Haematol (2001) 1.49
A collagen-like peptide stimulates tyrosine phosphorylation of syk and phospholipase C gamma2 in platelets independent of the integrin alpha2beta1. Blood (1997) 1.45
Human antibody fragments specific for human blood group antigens from a phage display library. Biotechnology (N Y) (1993) 1.40
Definition of novel GP6 polymorphisms and major difference in haplotype frequencies between populations by a combination of in-depth exon resequencing and genotyping with tag single nucleotide polymorphisms. J Thromb Haemost (2006) 1.39
Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med (1995) 1.31
ADP- and thapsigargin-evoked Ca2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets. J Biol Chem (1993) 1.31
Specific guanine nucleotide binding by membranes from Cucurbita pepo seedlings. Biochem Biophys Res Commun (1988) 1.19
Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Br J Haematol (1997) 1.18
Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus. J Thromb Haemost (2007) 1.18
Collagens and atherosclerosis. Exp Gerontol (1999) 1.17
Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome. Diabetologia (2008) 1.12
The tyrosine kinase inhibitors methyl 2,5-dihydroxycinnamate and genistein reduce thrombin-evoked tyrosine phosphorylation and Ca2+ entry in human platelets. FEBS Lett (1993) 1.09
Platelet endothelial cell adhesion molecule-1 is a negative regulator of platelet-collagen interactions. Blood (2001) 1.08
Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain. Arterioscler Thromb Vasc Biol (2001) 1.06
Micromolar Ca2+ concentrations are essential for Mg2+-dependent binding of collagen by the integrin alpha 2beta 1 in human platelets. J Biol Chem (2000) 1.05
Calcium store depletion in dimethyl BAPTA-loaded human platelets increases protein tyrosine phosphorylation in the absence of a rise in cytosolic calcium. Exp Physiol (1994) 1.03
The collagen-platelet interaction. Curr Opin Hematol (1998) 1.01
Integrin-independent tyrosine phosphorylation of p125(fak) in human platelets stimulated by collagen. J Biol Chem (2000) 0.99
A young woman with petechiae. Lancet (1998) 0.98
A human monoclonal antibody specific for the leucine-33 (P1A1, HPA-1a) form of platelet glycoprotein IIIa from a V gene phage display library. Blood (1995) 0.96
Monomeric (glycine-proline-hydroxyproline)10 repeat sequence is a partial agonist of the platelet collagen receptor glycoprotein VI. Biochem J (1999) 0.95
The effect of calcium-store depletion and refilling with various bivalent cations on tyrosine phosphorylation and Mn2+ entry in fura-2-loaded human platelets. Biochem J (1994) 0.95
Reactome - a curated knowledgebase of biological pathways: megakaryocytes and platelets. J Thromb Haemost (2012) 0.94
A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. J Thromb Haemost (2009) 0.93
Modulation of collagen production in cultured fibroblasts by a low-frequency, pulsed magnetic field. Biochim Biophys Acta (1985) 0.92
A role for adhesion and degranulation-promoting adapter protein in collagen-induced platelet activation mediated via integrin α(2) β(1). J Thromb Haemost (2012) 0.92
NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest (1992) 0.91
Collagen surfaces to measure thrombus formation under flow: possibilities for standardization. J Thromb Haemost (2011) 0.91
The Fc-receptor III of cultured human monocytes. Structural similarity with FcRIII of natural killer cells and role in the extracellular lysis of sensitized erythrocytes. J Immunol (1990) 0.90
Recent advances in understanding mechanically induced bone remodeling and their relevance to orthodontic theory and practice. Am J Orthod Dentofacial Orthop (1993) 0.89
No beneficial effect of low-dose fetal intravenous gammaglobulin administration in combination with intravascular transfusions in severe Rh D haemolytic disease. Vox Sang (1994) 0.88
Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domain. Int J Biochem Cell Biol (2011) 0.88
Immunologic and structural analysis of eight novel domain-deletion beta3 integrin peptides designed for detection of HPA-1 antibodies. J Thromb Haemost (2007) 0.88
Collagen-mimetic peptides mediate flow-dependent thrombus formation by high- or low-affinity binding of integrin alpha2beta1 and glycoprotein VI. J Thromb Haemost (2008) 0.88
A rapid one-stage whole-blood HPA-1a phenotyping assay using a recombinant monoclonal IgG1 anti-HPA-1a. Br J Haematol (2000) 0.88
Monoclonal antibodies identify residues 199-216 of the integrin alpha2 vWFA domain as a functionally important region within alpha2beta1. Biochem J (2000) 0.87
Characterization of human variable domain antibody fragments against the U1 RNA-associated A protein, selected from a synthetic and patient-derived combinatorial V gene library. Eur J Immunol (1996) 0.87
Nitric oxide specifically inhibits integrin-mediated platelet adhesion and spreading on collagen. J Thromb Haemost (2008) 0.86
Dual elevation of cyclic AMP and inositol phosphates in response to mechanical deformation of murine osteoblasts. Biochim Biophys Acta (1989) 0.85
A modified rapid monoclonal antibody-specific immobilization of platelet antigen assay for the detection of human platelet antigen (HPA) antibodies: a multicentre evaluation. Vox Sang (2007) 0.85
Human autoimmune anti-proteinase 3 scFv from a phage display library. Clin Exp Immunol (1997) 0.85
Effects of U73122 and U73343 on human platelet calcium signalling and protein tyrosine phosphorylation. Biochim Biophys Acta (1997) 0.84
Receptors and signalling mechanisms in the procoagulant response of platelets. Platelets (2000) 0.84
Three novel beta3 domain-deletion peptides for the sensitive and specific detection of HPA-4 and six low frequency beta3-HPA antibodies. J Thromb Haemost (2007) 0.84
The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 promotes enzymatic activity of matrixmetalloproteinase-2 in vitro. Eur J Microbiol Immunol (Bp) (2012) 0.84
Pulsed electromagnetic fields promote collagen production in bone marrow fibroblasts via athermal mechanisms. Calcif Tissue Int (1985) 0.84
Characterization of human blood group scFv antibodies derived from a V gene phage-display library. Br J Haematol (1994) 0.83
Convulxin binding to platelet receptor GPVI: competition with collagen related peptides. Biochem Biophys Res Commun (2000) 0.82
Signals elicited from human platelets by synthetic, triple helical, collagen-like peptides. Blood Coagul Fibrinolysis (1996) 0.82
Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage. Transfusion (1990) 0.82
Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens. Br J Haematol (2000) 0.82
Introduction to antibody engineering and phage display. Vox Sang (2000) 0.82
Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes. Blood (2000) 0.82
Overexpression of the partially activated alpha(IIb)beta3D723H integrin salt bridge mutant downregulates RhoA activity and induces microtubule-dependent proplatelet-like extensions in Chinese hamster ovary cells. J Thromb Haemost (2009) 0.81
Adult respiratory distress syndrome after experimental intravenous gamma-globulin concentrate and monocyte-reactive IgG antibodies. Lancet (1998) 0.81
Genotyping for platelet-specific antigens: techniques for the detection of single nucleotide polymorphisms. Vox Sang (2002) 0.81
Second messengers: regulators of mechanically-induced tissue remodelling. Eur J Orthod (1991) 0.81
Function of glycoprotein VI and integrin alpha2beta1 in the procoagulant response of single, collagen-adherent platelets. Thromb Haemost (1999) 0.81
Interlaboratory variation in the detection of clinically significant alloantibodies against human platelet alloantigens. Br J Haematol (1997) 0.81
Immunology of platelet disorders. Baillieres Clin Haematol (1989) 0.80
The use of collagen-based model peptides to investigate platelet-reactive sequences in collagen. Biopolymers (1996) 0.80
Tyrosine phosphorylation and Ca2+ influx. A further mechanism for store-dependent Ca2+ entry? Trends Pharmacol Sci (1994) 0.80
Leucine33-proline33 substitution in human platelet glycoprotein IIIa determines HLA-DRw52a (Dw24) association of the immune response against HPA-1a (Zwa/PIA1) and HPA-1b (Zwb/PIA2). Hum Immunol (1992) 0.80
The imidazole antimycotics econazole and miconazole reduce agonist-evoked protein-tyrosine phosphorylation and evoke membrane depolarisation in human platelets: cautions for their use in studying Ca2+ signalling pathways. Cell Calcium (1994) 0.80
Wortmannin inhibits store-mediated calcium entry and protein tyrosine phosphorylation in human platelets. FEBS Lett (1996) 0.80
Evidence for regulation of human platelet adenylate cyclase by phosphorylation. Inhibition by ATP and guanosine 5'-[beta-thio]diphosphate occur by distinct mechanisms. Biochem J (1991) 0.79
The platelet reactivity of synthetic peptides based on the collagen III fragment alpha1(III)CB4. Evidence for an integrin alpha2beta1 recognition site involving residues 522-528 of the alpha1(III) collagen chain. J Biol Chem (1997) 0.79
Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR). Lancet (1992) 0.79
Collaborative study to establish the first international standard for quantitation of anti-HPA-1a. Vox Sang (2005) 0.79
The isolation and characterisation of human monoclonal HLA-A2 antibodies from an immune V gene phage display library. Tissue Antigens (2000) 0.79
Activation of insect cell adenylate cyclase by Bacillus thuringiensis delta-endotoxins and melittin. Toxicity is independent of cyclic AMP. Biochem J (1988) 0.78
The importance of using multiple techniques for detection of platelet antibodies. Vox Sang (2007) 0.78
Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn. Br J Haematol (1988) 0.78
Fluid secretion by isolated Malpighian tubules of Drosophila melanogaster Meig.: effects of organic anions, quinacrine and a diuretic factor found in the secreted fluid. J Exp Biol (1999) 0.78
Molecular characteristics of anti-self antibody fragments against neutrophil cytoplasmic antigens from human V gene phage display libraries. Clin Exp Immunol (1995) 0.78
Report on the 13th International Society of Blood Transfusion Platelet Immunology Workshop. Vox Sang (2007) 0.77
Human platelet activation is inhibited upstream of the activation of phospholipase A2 by U73343. Biochem Pharmacol (1997) 0.77
Detection of human monocyte-reactive alloantibodies by flow cytometry after selective downmodulation of the Fc receptor I. Blood (1991) 0.77